Homepage
Medication Guide
What is the storage environment of WELIREG?
Belzutifan(WELIREG) is an innovative drug that offers a new treatment option for the treatment of von Hippel-Lindau (VHL) syndrome. So, what is the storage environment for WELIREG belzutifan?What is t...
506
Tuesday, June 24th, 2025, 11:41
Indications for Belzutifan
Belzutifan(Welireg) is a novel therapeutic drug specifically targeting tumors associated with von Hippel-Lindau (VHL) syndrome. It inhibits tumor growth by targeting HIF-2α and is indicated for specif...
509
Tuesday, June 24th, 2025, 11:33
Basic information about Belzutifan
Belzutifan (trade name Welireg) is a drug specifically used to treat diseased tissues associated with von Hippel-Lindau (VHL) syndrome. This article will discuss its basic information, purchase consid...
506
Tuesday, June 24th, 2025, 11:25
Vandetanib therapeutic effect
Vandetanib was approved by the U.S. Food and Drug Administration in 2011 for the treatment of unresectable locally advanced or metastatic medullary thyroid disease. Vandetanib has also been marketed i...
505
Monday, June 23rd, 2025, 17:54
What is the efficacy and effect of Caprelsa?
Vandetanib(Caprelsa) is a targeted drug used to treat unresectable locally advanced or metastatic medullary thyroid lesions. It helps patients prolong survival and improve quality of life by inhibitin...
505
Monday, June 23rd, 2025, 17:47
Best time to take Vandetanib
Vandetanib is a targeted drug used to treat unresectable locally advanced or metastatic medullary thyroid lesions. It blocks the growth and spread of diseased cells by inhibiting a variety of tyr...
505
Monday, June 23rd, 2025, 17:39
Indications for Vandetanib
Vandetanib is an orally targeted drug for specific thyroid disorders indicated for the treatment of unresectable locally advanced or metastatic medullary thyroid disease. The drug is approved in ...
507
Monday, June 23rd, 2025, 17:30
The place of Vandetanib in the treatment of lesions
Vandetanib is a targeted drug for the treatment of medullary thyroid lesions (MTC), especially in patients with unresectable locally advanced or metastatic medullary thyroid lesions. It has becom...
506
Monday, June 23rd, 2025, 17:12
Vandetanib(Caprelsa) is effective in inhibiting the growth and spread of lesions
Vandetanib, also known as Caprelsa, is a targeted drug used to treat unresectable locally advanced or metastatic medullary thyroid lesions. It significantly prolongs the survival of patients by inhibi...
508
Monday, June 23rd, 2025, 16:24
What side effects can Rucaparib cause?
Rucaparib is an orally active and potent inhibitor of polyadenosine diphosphate ribose polymerase (PARP). It is suitable for maintenance therapy of BRCA-mutated recurrent ovarian disease and BRCA...
504
Monday, June 23rd, 2025, 15:59
199 / 208
2075 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved